Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes by Kijlstra, Jan David et al.
Stem Cell Reports
ResourceIntegrated Analysis of Contractile Kinetics, Force Generation, and Electrical
Activity in Single Human Stem Cell-Derived Cardiomyocytes
Jan David Kijlstra,1,2,3,9 Dongjian Hu,1,2,4,9 Nikhil Mittal,5 Eduardo Kausel,6 Peter van der Meer,3
Arman Garakani,7 and Ibrahim J. Domian1,2,8,*
1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA
2Harvard Medical School, Boston, MA 02115, USA
3University Medical Center Groningen, University of Groningen, Groningen, 9713 GZ, the Netherlands
4Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA
5Institute of Bioengineering and Nanotechnology, 138669 Singapore
6Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
7Reify Corporation, Saratoga, CA 95070, USA
8Harvard Stem Cell Institute, Cambridge, MA 02138, USA
9Co-first author
*Correspondence: domian@mgh.harvard.edu
http://dx.doi.org/10.1016/j.stemcr.2015.10.017
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe quantitative analysis of cardiomyocyte function is essential for stem cell-based approaches for the in vitro study of human cardiac
physiology and pathophysiology. We present a method to comprehensively assess the function of single human pluripotent stem cell-
derived cardiomyocyte (hPSC-CMs) through simultaneous quantitative analysis of contraction kinetics, force generation, and electrical
activity. We demonstrate that statistical analysis of movies of contracting hPSC-CMs can be used to quantify changes in cellular
morphology over time and compute contractile kinetics. Using a biomechanical model that incorporates substrate stiffness, we calculate
cardiomyocyte force generation at single-cell resolution and validate this approach with conventional traction force microscopy. The
addition of fluorescent calcium indicators or membrane potential dyes allows the simultaneous analysis of contractility and calcium
handling or action potential morphology. Accordingly, our approach has the potential for broad application in the study of cardiac dis-
ease, drug discovery, and cardiotoxicity screening.INTRODUCTION
Advanced heart failure represents a leading cause ofmortal-
ity andmorbidity in the developed world. The clinical syn-
drome results from an inability of the cardiac output to
meet the metabolic demands of affected individuals.
Most commonly, this results from a loss of myocardial
cell viability or function (de Tombe, 1998; Narula et al.,
1998). Cardiomyocytes (CMs), the basic functional units
of themyocardium, produce force by shortening and thick-
ening during each contractile cycle to generate the forward
flow of blood. In vitro, myocardial function has been stud-
ied at the single-cell level or by myocardial muscle con-
structs as a surrogate for in vivo myocardium (Zimmer-
mann et al., 2006). The use of adult CMs isolated from
the myocardium of adult rodents and other animals for
in vitro studies of cardiac physiology and pathophysiology
has been an established method since the 1970s (Glick
et al., 1974). As a result, most techniques used to quantify
the contractility of CMs have been optimized for cells
with distinct edges and highly developed sarcomeres.
Recent advances in stem cell biology have greatly
increased the efficiency of cardiac differentiation of human
pluripotent stem cells (Lian et al., 2012). Human pluripo-
tent stem cell-derived cardiomyocytes (hPSC-CMs) are1226 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thnow used widely for in vitro studies (Sun et al., 2012) and
as cell sources for regenerative cardiovascular medicine
(Chong et al., 2014; Zimmermann et al., 2006). However,
hPSC-CMs display a relatively less mature phenotype and
often lack distinct cell edges and highly developed sarco-
meres, making the study of their contractility with tradi-
tional techniques difficult. This has prompted a number
of laboratories to focus on the functional maturation of
stem cell-derived CMs (Yang et al., 2014). Although prog-
ress has beenmade in this regard, the goal of culturing fully
mature human CMs from hPSC-CMs remains elusive,
highlighting the need for novel methods to functionally
characterize CMs at different developmental states.
Two widely used methods to quantify the contractile ki-
netics of adult CMs are edge detection and sarcomere length
measurements (Bub et al., 2010; Chen et al., 2014). Edge
detection technology relies on automatically detecting
changes in the position of the longitudinal edges of a CM
over time. Accordingly, its application must be optimized
for the scale, clarity, and orientation of the images being
analyzed. Commercially available edge detection tools
used to study CMs, for example, have been optimized to
detect the outer edges of horizontally aligned isolated adult
rod-like CMs that are either in suspension or attached to
glass (Chen et al., 2014). These tools are therefore not ideale Authors
for the assessment of hPSC-CMs with indistinct borders.
Moreover, glass is not an ideal substrate for CMs when
studying their contraction kinetics because the stiffness of
glass far exceeds the force generated by contracting CMs.
Alternative approaches for the quantification of contrac-
tility of adult CMs include assessment of the change of
sarcomere length over time. This approach requires the
presence of distinct sarcomeres (Bub et al., 2010) and is
therefore not very well suited for the study of hPSC-CMs.
Several approaches have been described recently for
analyzing motion in movies of beating hPSC-CMs, collec-
tively referred to as optical flow analysis. These approaches
include motion vector analysis after manual segmentation
(Ahola et al., 2014), block-matching algorithms combined
with motion vector analysis (Hayakawa et al., 2014),
or the evaluation of the correlation between intensity
vectors of frames within a movie (Maddah et al., 2015) to
yield a unit-less or dual-peaked curve representing the
beating signal. These approaches, however, do not directly
allow for the quantitative assessment of fractional short-
ening and force generation kinetics, key features of cardio-
myocyte physiology. CM force generation has been
assessed previously by a number of different methods,
including fluorescent microsphere-based traction force mi-
croscopy, atomic force microscopy, and micropost defor-
mation measurements (Liu et al., 2012; McCain et al.,
2014; Rodriguez et al., 2014). These techniques are highly
specialized, require advanced instrumentation, and cannot
be easily combined with optical measurements of contrac-
tile kinetics, measurements of calcium cycling, or action
potentials.
Here we present amethodology for the quantitative anal-
ysis of CM contractile kinetics and force generation that
can be used in hPSC-CMs as well as isolated adult CMs.
Our approach is not based on tracking the motion of parts
of the cell but, rather, on quantifying the total amount of
change in cell morphology over time. We use a previously
well validated statistical tool to analyze the similarity be-
tween frames in movies of contracting human embryonic
stem cell-derived cardiomyocytes (hESC-CMs) to generate
a similarity matrix. This matrix represents the change in
cell morphology over time and is used to compute the con-
tractile kinetics of hESC-CMs. We combine this methodol-
ogy with a biomechanical model to concurrently calculate
the CM force generation as the CMs deform a flexible sub-
strate. We validate this approach in human stem cell-
derived CMs as well as in murine adult myocardial cells at
single-cell resolution as well as in myocardial clusters. We
further demonstrate our ability to detect subtle changes
in the contractile kinetics and force generation of hESC-
CMs in response to pharmacological intervention with
isoproterenol and verapamil. Furthermore, we show that
our methodology can be applied simultaneously withStem Cell Repother single-cell physiological assays for the quantification
of calcium cycling and action potentials. Finally, we show
the utility of this method in assessing the cardiotoxicity
of drugs such as dofetilide.RESULTS
Morphologic Similarity Measure to Produce
Contraction Curves
The goal of this study is to generate a high-throughput un-
biased and robust methodology for the analysis of contrac-
tion kinetics and force generation of stem cell-derived CMs
that is compatible with fluorescence-based calcium cycling
and action potential assessment. We therefore performed
directed differentiation to generate hESC-CMs. On days
13–20 of in vitro differentiation, CMs were dissociated
into single-cell suspension and plated on a polydimethylsi-
loxane (PDMS) flexible substrate at single-cell density. By
culturing these CMs on the PDMS flexible substrate, the
cells could contract against strain (McCain et al., 2014). Af-
ter 14 days of culture on the flexible substrate, cells were
visualized in a temperature- and CO2-controlled chamber
by differential interference contrast (DIC) imaging as
described in the Experimental Procedures. We acquired
movies of the contracting cells at a temporal resolution of
at least 100 frames/s (fps).
As an example to illustrate ourmethodology, a 300-frame
movie at 100 fps of a single hESC-derived rod-like CM un-
dergoing a single contraction cycle was analyzed (Movie
S1). As shown, the CM of Movie S1 is in a pre-contractile
relaxed state between frames 1 (F1) and F140 and shortens
between F140 and F165 before returning to the baseline-
relaxed state. We first sought to determine the change in
cell morphology during these 300 frames. We therefore
quantitatively assessed the similarity of F1 to every other
frame in the movie by performing a pairwise similarity
comparison (SC) using a well established statistical tool
(Figure 1A; Garakani et al., 2015; Drubin et al., 2006; Gara-
kani, 2008; Hack et al., 2004; C.A. MacRae et al., 2005, In-
ternational Conference on Systems Biology, conference
presentation). This equation calculates the SC for all pairs
of frames captured at times i and j (i s j). Each pair of
frames is compared based on the color intensity of spatially
corresponding pixels defined by an intensity function
Ix,y,t’, where x and y are integers defining the coordinates
of a given pixel in a particular frame and t’ is an integer cor-
responding to the time of capture of the frame. The inten-
sity function values of all pixels in each frame are sum-
mated over N, where N is the total width 3 total height
of each frame. The similarity function is commutative so
that SCi,j = SCj,i. Furthermore, SCi,j = 1 if i = j. Therefore,
SC is defined as having a value between 0 and 1 where,orts j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 The Authors 1227
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Figure 1. Pairwise Similarity Comparison
of Frames in a Movie of a Contracting CM
(A) The equation to calculate SC between two
frames. Each pair of frames is compared based
on the intensity (grayscale value) of pixels in
the same location of the two frames. The
intensity is defined by the function Ix,y,i,
where x and y define the coordinates of a
given pixel in frame i. The values of all pixels
in each frame are summed over the frame area
(N). The similarity function is commutative
so that SCi,j = SCj,I. The SC of two identical
frames is defined as 1.
(B) A plot of SCs of frame F1 versus every
other frame of Movie S1. Blue, red, and green
arrows refer to the SCs for F1 versus F100,
F165, and F300, respectively.
(C) The digital difference between the
relaxed frame F1 (top) and the pre-contrac-
tile frame F100 (center) is displayed at the
bottom with the associated SC value.
(D) The digital difference between F1 (top)
and the contractile frame F165 (center) is
displayed at the bottom with the associated
SC value.
(E) The digital difference between F1 (top)
and the post-contractile frame F300 (center)
is displayed at the bottom with the associ-
ated SC value.
Scale bar, 10 mm. See also Movie S1.the more similar two frames are to each other, the closer
their SC value is to 1. We plotted the pairwise SC value of
F1 against every other frame, which yielded a preliminary
analysis of the contraction cycle (Figure 1B). The SC of
the relaxed frame F1 versus the pre-contractile frames F2–
F140 resulted in relatively high SC values (highly similar).
The SC values of F1 versus the contractile frames (F141–
F165) dropped dramatically (highly dissimilar). And,
finally, the SC values of F1 versus the post-contractile
frames returned to the high baseline value (again highly
similar).
To visually display the outcome of the SC analysis, we
used Fiji to calculate the digital differences between F1
and the pre-contractile frame F100. Spatially correspond-
ing pixels that have a similar intensity result in a dark pixel,
and corresponding pixels that have a less similar intensity
result in a lighter pixel. This calculation resulted in an
essentially black image with a faint, apparently random
white-speckled background and an associated SC of 0.923
because these two frames are both acquired while the cell
is in a relaxed state and very similar, although not identical.
(Figure 1C). The digital difference of F1 and the contractile
frame F165 resulted in a high-contrast black-and-white im-
age with an associated SC of 0.301, indicating a clear signal1228 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thbecause the change in cell morphology has resulted in a
change of the intensity of many pixels compared with
the corresponding pixels in the other frame (Figure 1D).
Finally, the digital difference between F1 and the post-con-
tractile frame F300 again yielded an essentially black image
with a faint white-speckled background and an associated
SC of 0.917 (Figure 1E).
In contrast, pairwise analysis of contractile frame F165 to
every other frame resulted in an inverted-appearing con-
tractile cycle (Figure 1F). The SC value of F165 versus the
relaxed frames was very low (highly dissimilar), became
progressively higher (more similar) for the contractile
frames, and dropped again for the post-contractile frames.
Likewise, the digital difference of F165 versus the pre-con-
tractile frame F100 was a high-contrast image with an asso-
ciated SC of 0.294 (Figure 1G). The digital difference of
F165 versus the contractile frame F166was essentially black
with a faint white-speckled background and an associated
SC of 0.930 (Figure 1H). And, finally, the digital difference
of F165 versus the post-contractile frame F300 was again a
high-contrast black-and-white imagewith an associated SC
value of 0.302 (Figure 1I).
To capture all of the similarity data in the movie, we per-
formed a pairwise comparison of each frame in Movie S1e Authors
Figure 2. Generation of the Contraction
Curve from the Similarity Matrix
(A and B) Three-dimensional graph (A)
displaying the similarity matrix (B) of Movie
S1, where the x and y axes display frame
numbers and the z axis displays the SC
value. The highlighted black lines display
the SC plots of F1 and F165 versus every
other frame. The blue, red, and green planes
map areas of the three-dimensional graph to
the associated portion of the matrix.
(C) Three-dimensional graph of the selected
pre-contractile SC curves.
(D) BASiC normalized to cell length and time
for the generation of a standard contraction
curve.
See also Figure S1 and Table S1.versus every other frame to produce a similarity matrix
of 300 rows 3 300 columns, where each row of the
matrix contains a series of SCs for a specific frame versus
every other frame (Table S1). The 300 3 300 similarity
matrix was then plotted as a series of similarity curves in
a three-dimensional graph (Figure 2A). Sample portions
of the 300 3 300 matrix are displayed (Figure 2B), with
the left showing the pairwise comparison of pre-contractile
frames F1–F5 versus F1–F5 (all highly similar), the center
showing F1–F5 versus contractile frames F163–F168 (high-
ly dissimilar), and the right showing F1–F5 versus post-con-
tractile frames F210–214 (all highly similar again).
To obtain a more physiological assessment of the CM
contraction cycle, we used the average of the similarity
curves of pre-contractile frames (Figure 2C) as the baseline
for the maximally relaxed state. We defined the pre-con-
tractile period as the terminal 15% of the inter-contraction
interval, as determined by a rolling linear regression anal-
ysis of all frames (Figures S1A and S1B). Next we averaged
these similarity curves to obtain the baseline adjusted sim-
ilarity comparison (BASiC) curve. We then normalized the
maximum and minimum SC values to manually measured
cell length at end-diastole and peak systole (as described in
detail in the Supplemental Experimental Procedures). ThisStem Cell Repallowed us to generate a normalized contraction curve of
CMs with percent cell length plotted against time (Fig-
ure 2D). Manually measured cell length measurements
were highly similar between independent observers, with
a mean difference of 0.3 mm (95% limit of agreement,
1.8–1.2 mm; Figure S1C).
We then empirically validated this quantitative analysis
and demonstrated that the BASiC-generated cell length
curves correlate with contraction curves generated by
manual cell length measurement, automated edge detec-
tion measurement, and sarcomere length measurement
with Pearson’s correlation coefficients of greater than
0.98 in adult murine CMs (Figures 3A, 3C, and 3E; Movie
S2). We then repeated a similar type of analysis on rod-
like hESC-CMs and demonstrated that BASiC-generated
cell length curves were highly correlated with manual cell
length curves, with Pearson’s correlation coefficients of
0.98 (Figures 3B, 3D, and 3E; Movie S1). Importantly, auto-
mated edge detection methods could not generate usable
contraction curves for hESC-derived CMs because of the
relatively low-contrast edges of these cell types, high-
lighting the need for an automated alternative to edge
detection. Similarly, these cells do not have well developed
sarcomeres.orts j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 The Authors 1229
Figure 3. Validation of Contraction Curve
in IsolatedAdultMurine CMsandhESC-CMs
(A and B) Comparison of representative iso-
lated murine adult CMs (A) and hESC-CMs (B)
in a relaxed (top) versus a contracted (bot-
tom) state. Solid white lines represent the
position of cell edges in a relaxed state.
Dotted white lines represent the position of
cell edges in a contracted state. Scale bars,
10 mm.
(C and D) Contraction curves generated by
manual measurement (black line), edge
detection (blue line), sarcomere length
measurement (yellow line), and BASiC (red
line) of the representative murine adult CM
(C) and the representative hESC-CM (D).
(E) Pearson’s correlation coefficient (Pear-
son’s r) between contraction curves gener-
ated by manual measurement (M), edge
detection (ED), sarcomere length measure-
ment (SL), and BASiC (Ba) of adult CMs
(black bar, n = 15 cells from 3 independent
experiments) and hESC-CMs (gray bar, n = 16
cells from 3 independent experiments).
Data are represented as mean ± SE. See also
Figure S2 and Movies S1 and S2.In addition, we analyzed the similarity between contrac-
tion curves generated by BASiC andmanual measurements
of irregularly shaped hESC-CMs cultured on PDMS (i.e.,
non-rod-like), hESC-CM clusters cultured on PDMS or in
suspension, and hESC-CM monolayers on polystyrene
(Figures S2A–S2I). We found Pearson’s correlation coeffi-
cients of above 0.95 under all of these conditions, indi-
cating the applicability of BASiC to analyze CM contrac-
tility in variable setups. Further testing revealed that
differences in frame rate, light intensity, and resolution
during image acquisition had a minimal effect on BASiC
analysis (Figures S2J–S2O).
Mechanical Model for Quantification of Force
Generation
We then sought to quantify the force generated by individ-
ual CMs by traction force microscopy (TFM), a well vali-
dated methodology used to estimate the force generated
by individual CMs (McCain et al., 2014). In traditional
TFM, cells are plated on flexible substrates with fluorescent
microspheres attached to the surface of the substrate. As
cells shorten, they deform the substrate and, with it,
move the attached fluorescent microspheres. Because the
stiffness of the substrate is known, it is possible to estimate
the contractile force required for its deformation from the
movement of the fluorescent microspheres. Because cell
shortening is not measured directly but, rather, inferred
from microsphere movement, this approach relies on the1230 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thassumption that microsphere movement and cell short-
ening are directly correlated. To test this underlying
assumption, we cultured hESC-CMs on flexible PDMS sub-
strates embedded with fluorescent microspheres. Cell
shortening correlated closely with microsphere move-
ment, validating this assumption (Figure S3A; Movie S3).
We then calculated the force generated by single contract-
ing rod-like CMs from the microsphere movement (Figures
4A, 4E, and 4F) with standard techniques and obtained re-
sults similar to previous reports (Kuo et al., 2012; McCain
et al., 2014). An important limitation of standard TFM ap-
proaches is the use of fluorescently labeled microspheres,
limiting their compatibility for use in conjunction with
fluorescence-based physiological assays such as optical
mapping of calcium cycling and action potential. To
address this limitation and capitalize on the power of our
methodology, we utilized a mechanical model based on
cell dimensions, cell shortening, and growth substrate
properties to calculate the force generated by single con-
tracting myocytes without the use of fluorescent micro-
spheres (described in detail in the Supplemental Experi-
mental Procedures). A direct comparison of both TFM
methodologies (with and without microspheres) revealed
highly similar force curves with a mean Pearson’s correla-
tion coefficient of 0.96 (Figures 4B and 4C). Likewise,
the mean difference in peak force was 8.8 mN/mm2 (95%
limits of agreement, 33.8–16.2 mN/mm2; Figure 4D). We
then repeated these experiments with irregularly shapede Authors
Figure 4. TFM with and without Fluores-
cent Microspheres for Single-Cell Force
Measurement
(A) Top: image of the PDMS surface coated
with 200 mM fluorescent microspheres. The
yellow outline indicates the outline of the
CM at its fully contracted state. Bottom: DIC
image of the CM. Scale bar, 10 mm.
(B) Plot of contractile force calculated
by TFM using BASiC overlaid with force
calculated by TFM using fluorescent micro-
spheres.
(C) Pearson’s r between contraction curves
generated by the two methods. n = 11 cells
from 3 independent experiments.
(D) Bland-Altman graph showing the
average of force measured by TFM using
BASiC and TFM using fluorescent micro-
spheres plotted against the difference in
measurements. The mean difference
(dashed line) and 95% limit of agreement
(dotted lines) are indicated. n = 10 cells
from 3 independent experiments.
(E) Microsphere displacement heatmap
(top) and vector map (bottom) of the CM at
its peak contraction state compared with its
relaxed state.
(F) Traction force heatmap (top) and vector
map (bottom) of the CM at its peak
contraction compared with its relaxed state.
Data are represented as mean ± SE. See also
Figure S3 and Movie S3.hESC-CMs and CM clusters on PDMS and again found
highly similar force curves with average Pearson’s correla-
tion coefficients of above 0.95. The ratio of peak force
calculated by TFM with BASiC over peak force calculated
by TFM with microspheres was 1.02 ± 0.04 for CM clusters
and 1.40 ± 0.15 for irregularly shaped CMs (Figures S3B–
S3G). The correlation in force calculations between TFM
withmicrospheres and BASiCwas not affected by the appli-
cation of the non-selective b-adrenergic agonist isoproter-
enol (Figures S3H and S3I).
Quantification of Pharmacotherapy Effects
To evaluate the sensitivity of ourmethodology in detecting
small changes in the contractile behavior of individual
hESC-CMs, we examined the dose response of two bioac-Stem Cell Reptive agents used widely in cardiovascular research. Verap-
amil is an L-type calcium channel blocker that has been
shown to decrease CM contractility (Dolnikov et al.,
2006; Turnbull et al., 2014). Conversely, isoproterenol
has been shown to increase CM contractility (Brito-Martins
et al., 2008). hESC-CMs were paced with field stimulation
at a rate of 1.2 Hz, and movies of single rod-like CMs
contracting on PDMS gels were captured at baseline and
after treatment with 10 and 100 nM of verapamil or isopro-
terenol. CM contraction curves were then generated as
described above. Calcium cycling was also concurrently as-
sessed via fluorescence imaging with the calcium dye Fluo-
4 AM. In a control experiment, the effect of Fluo-4 AM on
hESC-CM contractility was analyzed over a period of
60 min, and no significant differences in contractilityorts j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 The Authors 1231
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Figure 5. Quantitative Analysis of CM Function in Response to Verapamil
(A) Representative contraction curves of a single field-stimulated hESC-CM treated with the L-type calcium channel blocker verapamil.
Changes in Fluo-4 AM calcium transient indicator intensity (top), percentage cell length (center), and contractile force (bottom) of the
cell over time are shown.
(B–G) Fold change in calcium transient amplitude (DF/F0, B), peak force (PF, C), maximum shortening velocity (DL/Dt, D), maximum
relengthening velocity (+DL/Dt, E), time to 50% peak shortening (TPS50, F), and time to 90% relengthening (TR90, G) of cells treated
with 10 and 100 nM verapamil compared with baseline. n = 8 cells from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001; ns, not significant.
Data are represented as mean ± SE. See also Figure S4 and Movie S4.were found (Figure S4A–S4G). In an additional control
experiment with hESC-CMs, the calcium dye inten-
sity remained stable over a period of 60 min (Figure S4H).
Treatment with verapamil resulted in decreased contrac-
tility and calcium transients, as assessed by fluorescent
signal, fractional shortening, and force curves (Figure 5A;
Movie S4). Quantitative analysis of the contraction kinetics
and calcium cycling revealed negative inotropic and lusi-
tropic effects on CM contractility by the administration
of verapamil, with a significant reduction in maximum
shortening velocity, peak contractile force, maximum re-
lengthening velocity, and calcium transient amplitude
(Figures 5B–5G). In contrast, treatment with isoproterenol
resulted in progressive positive inotropic and lusitropic ef-
fects with a significant increase in maximum shortening
velocity, peak contractile force, and maximum relengthen-
ing velocity. We also observed significant decreases in time
to 50% peak shortening and time to 90% relengthening
(Figure 6). We analyzed the responses to these pharmaco-
logical interventions as the average fold change ofmultiple1232 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thcells. As expected, because of the heterogeneous nature of
hESC-CMs, there was some degree of variability in the
functional characteristics of these myocytes at baseline
and in response to verapamil (Figure S4I–S4N) and isopro-
terenol (Figures S5A–S5F). Subsequently, isolated adult
mouse CMs field-stimulated at 1 Hz were treated with
100 nM isoproterenol, contraction curves were generated
with BASiC, and a significant positive inotropic effect was
again observed (Figure S5G–S5M).
Fluorescent transmembrane voltage reporters have
been used previously to study toxic electrophysiological
changes after treatment with anti-arrhythmic drugs such
as dofetilide, a blocker of the rapid component of the de-
layed rectifier current (IKr). Prior work has demonstrated
that dofetilide prolongs the cardiac action potential and
can be proarrhythmic at clinically prescribed doses (Ley-
ton-Mange et al., 2014; Roden, 2004). Most studies to
date, however, have examined the effect of such drugs
exclusively on action potential characteristics (Braam
et al., 2010; Leyton-Mange et al., 2014). We hypothesizede Authors
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Figure 6. Quantitative Analysis of CM Function in Response to Isoproterenol
(A) Representative contraction curves of a single field-stimulated hESC-CM treated with the b agonist isoproterenol. Changes in Fluo-4 AM
calcium transient indicator intensity (top), percentage cell length (center), and contractile force (bottom) of the cell over time are shown.
(B–G) Fold change in DF/F0 (B), PF (C), DL/Dt (D), +DL/Dt (E), TPS50 (F), and TR90 (G) of cells treated with 10 and 100 nM
isoproterenol compared with baseline. n = 9 cells from 3 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Data are represented as mean ± SE. See also Figure S5.that, by concurrently examining CM contractility and ac-
tion potential characteristics, we would be able to better
assess the cardiotoxicity of such commonly used drugs.
Movies of single rod-like CMs contracting on PDMS gels
were captured at baseline and after treatment with 10 nM
dofetilide. Action potential morphology was concurrently
assessed via fluorescence imaging with the transmembrane
voltage reporter FluoVolt (Miller et al., 2012). At baseline,
hESC-CMs exhibited regular intervals between action po-
tentials and contractions, with consistent peak amplitudes
even in the absence of field stimulation (Figure 7A). Upon
treatment with the arrhythmogenic agent dofetilide, how-
ever, cells exhibited multiple toxic responses, including
early afterdepolarizations (Figure 7B; Movie S5), irregular
interbeat intervals (IBIs; Figure 7C), and irregular contrac-
tion peak amplitudes (PAs; Figure 7D). We then quantified
the coefficient of variation (COV) for both the IBI and PA
for the cells before and after dofetilide treatment and
compared the measurements for the action potential pro-
file and the contractility profile. Although some of the
toxic effects were identified in both the action potential
and contraction profiles, others were only apparent in theStem Cell Repcontraction curve, highlighting the need to examine exci-
tation-contraction coupling after treatment with poten-
tially cardiotoxic agents.DISCUSSION
The advent of human induced pluripotent stem cell tech-
nology coupled to advances in directed cardiac differentia-
tion protocols has opened new avenues for the study of
human myocardial physiology and pathophysiology.
Recent studies have focused on disease-specific human
induced PSC-CMs’ electrophysiology and calcium cycling
properties for cardiac disease modeling or, alternatively,
on myocardial contractility (Itzhaki et al., 2011; Lan
et al., 2013). To date, the simultaneous assessment of cal-
cium cycling, action potential characteristics, contractile
kinetics, and force generation has been challenging. Cur-
rent methodologies geared at assessing myocardial con-
tractility of adult CMs typically rely on edge detection
techniques that directly assess CM shortening (Chen
et al., 2014) or the change in sarcomere striations overorts j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 The Authors 1233
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Figure 7. Rapid Evaluation of Drug-
Induced Cardiac Toxicity in Single Cardio-
myocytes
(A) Representative contraction curves of a
single spontaneously contracting CM at
baseline (0 nM dofetilide). Changes in
FluoVolt action potential indicator intensity
(top), percentage cell length (center), and
contractile force (bottom) of the cell over
time are shown.
(B–D) Representative contraction curves
of single CMs treated with 10 nM of dofeti-
lide showing occurrences of early after-
depolarizations (closed arrows) without
aftercontractions (closed arrowheads) (B),
irregular interbeat intervals (IBIs) and peak
contraction amplitudes (PAs) (C), and ab-
sent contractions (open arrowheads) with
regular action potential (open arrows) in
addition to irregular IBIs and PAs (D).
(E) The coefficient of variation (COV) of
the IBIs measured by action potential (AP)
and BASiC treated with (+) and without ()
dofetilide.
(F) The COV of the PAs measured by AP
and BASiC treated with (+) and without ()
dofetilide. *p < 0.05, **p < 0.01. n = 10 cells
from 3 independent experiments.
Data are represented as mean ± SE. See also
Movie S5.time (Bub et al., 2010). These approaches require cells with
clearly defined cellular borders and distinct striations,
limiting their applicability to less mature cell types (Gher-
ghiceanu et al., 2011). Likewise, current TFM approaches
for the measurement of contractile force of single myocar-
dial cells require the use of fluorescent microspheres,
limiting their capacity for use in conjunction with other
fluorescence-based physiological assays. Other approaches,
including optical flow analysis, yield a unit-less or dual-
peaked curve rather than standard fractional shortening
and force generation curves (Ahola et al., 2014; Hayakawa
et al., 2014; Maddah et al., 2015).
Here we present a methodology that provides a flexible
tool for the study of contraction kinetics of single myocar-
dial cells at different stages of maturation cultured on sub-1234 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thstrates with tunable stiffness. Our approach is based on
comparing the similarity of frames in a movie of CMs con-
tracting on well characterized flexible substrates and yields
a standard contraction curve of hPSC-CMs contracting
against strain. Critically, this allows the generation of frac-
tional shortening curves and the calculation of contraction
and relaxation velocities similar to those used in many
studies of adult cardiomyocytes. We then incorporate the
mechanical properties of the growth substrate to quantify
the kinetics of force generation at single-cell resolution
and in myocardial clusters. We demonstrate that our
approach is ideally suited for rod-like cells and myocardial
clusters and has a high degree of correlation with standard
TFM, which requires the use of fluorescent microspheres.
Because we do not use fluorescence for the assessment ofe Authors
force generation, our approach is readily suitable for
the concurrent assessment of the kinetics of force genera-
tion along with calcium cycling and action potential at
single-cell resolution. An important advantage of the
simultaneous assessment of force generation and electro-
physiological characteristics is the ability to unequivocally
determine whether a pathophysiological process results
in electromechanical dissociation. Because our approach
yields fractional shortening curves, it should also allow
an easier comparison of the contractile phenotype between
hPSC-CMs and adult CMs in maturation studies, disease
modeling, and pharmacological experiments. Importantly,
our method is economical and widely applicable because it
only requiresmoviemicroscopywithout the need for high-
ly specialized hardware or genetically engineered cell lines.
Although our approach does not currently offer real-time
analysis, it can be automated readily to allow for this in
the future.
In proof-of-principle experiments, we examined the res-
ponse of hESC-derived CMs to verapamil and isoproter-
enol, two drugs commonly used in cardiovascular research.
Single CMs exhibited a significantly reduced calcium
transient amplitude associated with a negative inotropic
response to treatmentwith the L-typeCa2+ channel blocker
verapamil. These results are in accordance with previous re-
ports from hPSC-CM-based tissue-engineered heart tissues
(Turnbull et al., 2014), embryoid bodies (EBs; Dolnikov
et al., 2006), and hPSC-CM monolayers (Himmel, 2013).
Likewise, we observed a dose-dependent positive inotropic
response to isoproterenol. Prior studies using hPSC-CMs
have found a variable inotropic response to isoproterenol.
Although some studies show a significant inotropic
response in EBs and single hPSC-CMs (Hayakawa et al.,
2014; Reppel et al., 2004), other studies show a transient
or no response in EBs and engineered heart tissue (Brito-
Martins et al., 2008; Turnbull et al., 2014).
Over the past decades, numerous drug development pro-
jects have been halted by concerns over cardiotoxicity.
Because significant differences exist between humans and
rodents, hPSC-CMs have been suggested as a promising
alternative to rodent adult CMs. Several studies using
hPSC-CMs for cardiotoxicity screening have been per-
formed with different readouts of toxicity, such as
increased action potential duration and the occurrence of
early afterdepolarizations (Braam et al., 2010; Liang et al.,
2013). We demonstrate our ability to rapidly detect drug-
induced cardiac toxicity by assessing contractility and
action potential simultaneously. Our finding that excita-
tion-contraction coupling may be perturbed under toxic
conditions suggests that simultaneously assessing action
potential characteristics and contractile behavior may
improve the sensitivity of drug-induced cardiac toxicity
screening.Stem Cell RepThe treatment of heart failure represents a major unmet
clinical need. Despite the recent advances in regenerative
medicine, at this time, drug-based therapy remains the
cornerstone of treatment for heart failure. Our methodol-
ogy should have broad applications in the study of normal
and diseasedmyocardial contractile physiology and should
be suitable for drug discovery and toxicology testing using
normal or diseased stem cell-derived myocardial cells.EXPERIMENTAL PROCEDURES
Generation of Flexible Culture Substrates
Flexible substrates were generated by adding 50 ml of Sylgard 527
PDMS, parts A and B mixed at a 1:1 ratio, onto a Fluorodish
(WPI) and curing at 60C for 6 hr.(Palchesko et al., 2012) Subse-
quently the FluorodisheswereUV-sterilized and coatedwithMatri-
gel (BD Biosciences) prior to cell seeding.
Human Embryonic Stem Cell Maintenance and
Cardiac Differentiation
hESCs from the lines HUES-9 and HES-3 NKX2-5eGFP/w were
culturedwithmTESR-1 growthmedium (STEMCELLTechnologies)
in polystyrene plates coated with Matrigel (BD Biosciences) as
described previously. Cardiac differentiation of hESCs was per-
formed using a protocol established previously (Lian et al., 2012).
Fluorescence-Activated Cell Sorting
The simultaneous DIC imaging with fluorescent calcium imaging
experiment was performed with GFP+ HES-3 NKX2-5eGFP/w cells.
Cells were isolated with a fluorescence-activated cell sorting
(FACS) protocol as described previously (Elliott et al., 2011).
Dissociation and Plating
Beating CMs were dissociated into single-cell suspensions after
15–20 days of differentiation as described previously (Atmanli
et al., 2014). Single hESC-CMs were seeded onMatrigel-coated Flu-
orodishes at 2,000—6,000 cells/cm2. Single contracting CMs and
CM clusters growing on PDMS substrates for more than 2 weeks
were chosen for drug treatment and image acquisition. To obtain
hESC-CM clusters in suspension, beating CMs were treated
with 0.05% Trypsin (Life Technologies) for 5 min, after which
the reaction was neutralized with 10% fetal bovine serum (Life
Technologies).
Confocal Imaging and Drug Treatment
Single contracting CMs and CM clusters cultured on flexible sub-
strates, CMclusters in suspension, andCMmonolayers on polysty-
rene were imaged in CM culture medium using a Nikon A1R
confocal microscope atop an anti-vibration table (TMC). Cells
were placed inside a climate control chamber at 37C with 5%
CO2 (Pathology Devices) 30 min prior to the start of the ex-
periments. For the verapamil and isoproterenol experiments, the
cells were field-stimulated with 10 V at 1.2 Hz using the RC-
37WS perfusion insert with electrodes (Warner Instruments) con-
nected to a C-Pace EP stimulator (Ion Optix). Movie recording oforts j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 The Authors 1235
CM contraction cycles was performed using a Nikon A1R confocal
microscope with DIC microscopy using a 488- or 647-nm laser.
Movies were acquired with at least 100 fps unless described other-
wise.Movies of CMs displaying at least five contraction cycles were
recorded at baseline and then 5 min after each treatment. Cells
were treated with verapamil (Sigma), isoproterenol (Sigma), or do-
fetilide (Sigma) as described in the Results. For calcium imaging,
0.5 mM of Fluo-4 AM (Life Technologies) was added to the CM
culture medium 10 min prior to image acquisition. For action
potential imaging, a FluoVolt membrane potential kit (Life
Technologies) was used at a dilution of 1:1,000 according to the
manufacturer’s protocol. Both fluorescence and DIC channels
were recorded concurrently for multiple contraction cycles.
Data Analysis and Display
The Nikon Elements software package and Fiji were used formovie
file conversions.(Schindelin et al., 2012). Movies were cropped us-
ing Fiji to isolate the contracting CM from neighboring cells and
cellular debris. Movies were loaded into Visible software (Reify)
(Garakani et al., 2015; Drubin et al., 2006; Garakani, 2008; Hack
et al., 2004; C.A. MacRae et al., 2005, International Conference
on Systems Biology, conference presentation) to generate a similar-
itymatrix of n rows by n columns, where n is the number of frames
in the movie. Analysis of the similarity matrix was performed in
Excel (Microsoft). For analysis of contraction curves, at least five
contraction curves from a single video were averaged by matching
the start of the contractions. Curve-fitting was applied to this aver-
aged curve to obtain accurate measurements of maximum short-
ening and relengthening velocities and time to 50% shortening
and 90% relengthening, respectively. The three-dimensional
matrices were generated using GNU Octave and MATLAB
(MathWorks).
Traction Force Microscopy with Fluorescent
Microspheres
We used a well established fluorescent microsphere-based method
to calculate the contractile force of CMs (Hazeltine et al., 2012;
McCain et al., 2014). Briefly, fluorescentmicrospheres (Invitrogen)
were coated onto PDMS substrates. The substrates were then UV-
sterilized and coated with Matrigel (BD Biosciences). CMs were
seeded onto the substrates and cultured for 14 days. Movies of
single CMs and CM clusters contracting on the substrates were re-
corded in both fluorescent and DIC channels. The software pack-
age TractionForAll (Marinkovic et al., 2012) was used to analyze
images from the movies and calculate the force generated by CMs.
Traction Force Microscopy without Fluorescent
Microspheres
Contractile forces generated by shortening CMs were calculated in
MATLAB based on the contractility curve generated with BASiC,
the dimensions of the CM, and the mechanical properties of the
PDMS substrate (Palchesko et al., 2012). Variable input for the
MATLAB script is the width of the cell in centimeters, the length
of the cell (in the direction of contraction) in centimeters, and
the amount of cell shortening in centimeters. The Young’s
modulus of PDMS substrates was 5 kPa for all experiments. The
MATLAB script and related mechanical model are based on several1236 Stem Cell Reports j Vol. 5 j 1226–1238 j December 8, 2015 j ª2015 Thassumptions, described in detail in the Supplemental Experi-
mental Procedures.
Statistical Analysis
All data were analyzed using GraphPad Prism 6 software (Graph-
Pad Software) and presented as means ± SE from the number of
cells indicated in the text and figure legends. Raw data were
analyzed for normal distribution using the Kolmogorov-Smirnov
test. Contraction kinetics and force generation data were com-
pared using repeated-measures ANOVA followed by Bonferroni
post-test analysis for multiple comparisons. Coefficient of varia-
tion data were compared using paired t test. Force generation
data after calculation with two different TFM methods before
and after application of isoproterenol were compared using
repeated-measures two-way ANOVA. Differences were considered
significant at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, five figures, one table, and eight movies and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2015.10.017.
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